The Willamette Funds of Portland, Ore., is planning to introduce a new fund that will invest in companies that have received venture capital financing, according to a preliminary prospectus filed Jan. 19 with the Securities and Exchange Commission.

The Willamette Post-Venture Capital Fund will invest at least 65 percent of its assets in securities of companies that have received venture capital within the past 10 years, according to the filing. Also, the fund will invest 35 percent of its assets in companies located outside the U.S. The fund's managers will invest in companies that have distributed shares to venture capitalists in the early stages of their development or companies that have had an IPO, according to the filing.

The fund is one of five offered by the Willamette Funds. The firm is re-issuing four of its existing funds under their current names because the firm's current registered investment company, the Coventry Group of Columbus, Ohio, is being replaced by Willamette Asset Management, of Portland, Ore., the adviser to the Willamette Funds. Willamette Asset Management is willing to become the adviser to the funds because the funds have reached a sufficient size, a spokesperson for the firm said.

There is a total of approximately $100 million in assets in the Willamette Global Health Sciences Funds, Small Cap Growth Fund, Technology Fund and Value Fund, according to the spokesperson.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.